Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Kumar Madassery, MD, director of peripheral vascular intervention and critical limb ischemia (CLI) program at Rush University Medical Center in Chicago, explains techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation. He is part of a campaign to raise awareness through the PAD Pulse Alliance.

Interventional techniques can help limit amputations among CLI patients

Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.

March 19, 2024
Hoping to improve care for these patients, Hermann et al. turned to the ŌNŌ retrieval system, a catheter-delivered device cleared by the U.S. Food and Drug Administration in 2022. The device was developed by Ōnōcor, a U.S. healthcare startup with roots in the Penn Center for Innovation.

Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system

A team of specialists in Houston made history, using the new-look device to treat three patients over the age of 80. The group shared its experience in JACC: Clinical Electrophysiology.

March 19, 2024
Biotronik has received the FDA’s breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS) for patients with chronic limb-threatening ischemia (CLTI).

FDA grants new resorbable scaffold for CLTI its breakthrough device designation

Biotronik's Freesolve technology, which gained CE mark approval in February, is designed to maximize blood flow and minimize the post-implantation risks of stent thrombosis and target lesion revascularization.

March 18, 2024
The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease

Researchers also found that CABG and PCI were each associated with their own advantages and disadvantages, highlighting the importance of shared decision-making. 

March 15, 2024
Sapien 3 Ultra Resilia TAVR valves

Edwards, Abbott share updated TAVR data at CRT 2024

Some of the world’s biggest names in interventional cardiology and structural heart disease gathered in Washington, D.C., for the four-day event. 

March 15, 2024
With a growing shortage of cardiologists in the U.S., there is growing interest recruiting more clinicians from overseas. But there are barriers to this, approach explained Abdel Almanfi, MD, FACC, FSCAI, a structural heart interventional cardiologist at Baylor St. Luke's Medical Center in Houston, Texas. He spoke with Cardiovascular Business and shared his journey from Libya to the United States, shedding light on the challenges foreign doctors face in realizing their dreams of practicing in America.

Cardiologist shares his long journey from Libya to United States

Abdel Almanfi, MD, went through years of training in Libya, but then he had to start over once he landed in the United States. 

March 15, 2024
On the frontline of the epidemic of peripheral artery disease (PAD) and related 400 leg amputations per day in the U.S., Kumar Madassery, MD, director of peripheral vascular intervention and critical limb ischemia (CLI) program at Rush University Medical Center in Chicago, explains there is a glaring health inequities in rural and low income areas of the country.

Peripheral artery disease is out of control in many rural, low income communities

Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late. 

March 14, 2024
Boston Scientific’s Agent Drug-Coated Balloon (DCB), which delivers a therapeutic dose of the anti-proliferative drug paclitaxel to the patient’s scar tissue to prevent ISR from recurring, gained FDA approval on March 1..

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

March 14, 2024
Displaying 41 - 48 of 1374

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup